Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth

Oncogene
Michal MazorRobert M Kypta

Abstract

The transcriptional activity of the androgen receptor (AR) is regulated by interaction with various coregulators, one of which is beta-catenin. Interest in the role of beta-catenin in prostate cancer has been stimulated by reports showing that it is aberrantly expressed in the cytoplasm and/or nucleus in up to 38% of hormone-refractory tumours and that overexpression of beta-catenin results in activation of AR transcriptional activity. We have examined the effect of depleting endogenous beta-catenin on AR activity using Axin and RNA interference. Axin, which promotes beta-catenin degradation, inhibited AR transcriptional activity. However, this did not require the beta-catenin-binding domain of Axin. Depletion of beta-catenin using RNA interference increased, rather than decreased, AR activity, suggesting that endogenous beta-catenin is not a transcriptional coactivator for the AR. The glycogen synthase kinase-3 (GSK-3)-binding domain of Axin prevented formation of a GSK-3-AR complex and was both necessary and sufficient for inhibition of AR-dependent transcription. A second GSK-3-binding protein, FRAT, also inhibited AR transcriptional activity, as did the GSK-3 inhibitors SB216763 and SB415286. Finally, inhibition of GSK-3 re...Continue Reading

References

Apr 1, 1991·Neuropathology and Applied Neurobiology·J E MartinP N Leigh
Aug 26, 1999·In Vitro Cellular & Developmental Biology. Animal·R M SramkoskiJ W Jacobberger
Feb 19, 2000·Biochemical and Biophysical Research Communications·A Kikuchi
Aug 11, 2000·Science·S E RossO A MacDougald
Sep 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·R V BhatC M Lee
Aug 31, 2001·Progress in Neurobiology·C A Grimes, R S Jope
Oct 2, 2001·Science's STKE : Signal Transduction Knowledge Environment·J R Woodgett
Nov 15, 2001·The Journal of Biological Chemistry·Elizabeth FraserTrevor C Dale
Jan 17, 2002·The Journal of Biological Chemistry·Fajun YangZijie Sun
Feb 22, 2002·The Journal of Biological Chemistry·David J MulhollandColleen C Nelson
Sep 12, 2002·The Journal of Biological Chemistry·Jonathan Franca-KohTrevor C Dale
Dec 6, 2002·Oncogene·Dennis R Chesire, William B Isaacs
Mar 5, 2003·Journal of Cell Science·Bradley W Doble, James R Woodgett
Apr 30, 2003·Nature·Tannishtha ReyaIrving L Weissman
Jul 23, 2003·The Journal of Biological Chemistry·Francesca DemarchiClaudio Schneider
Jan 10, 2004·Endocrine-related Cancer·D R Chesire, W B Isaacs
Feb 27, 2004·The Journal of Biological Chemistry·Thomas R SalasDavid G Menter

❮ Previous
Next ❯

Citations

Dec 14, 2011·Analytical Chemistry·Michael D ScottSanku Mallik
Jun 20, 2012·Nature Reviews. Urology·Robert M Kypta, Jonathan Waxman
Jun 16, 2012·Molecular BioSystems·Jae-Kyung Myung, Marianne D Sadar
Jan 8, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sheng-Hao WangChwen-Ming Shih
Jan 9, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Akiva P NovetskyPaul J Goodfellow
Sep 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrei V OugolkovDaniel D Billadeau
Aug 7, 2013·Molecular Cancer·Bastian Hoesel, Johannes A Schmid
Nov 30, 2010·Journal of Experimental & Clinical Cancer Research : CR·Yanni HuYouhua Xu
Mar 25, 2006·Future Oncology·Andrei V Ougolkov, Daniel D Billadeau
Feb 2, 2013·Journal of Enzyme Inhibition and Medicinal Chemistry·Tarek M K MotawiMohamed A S Al-Ghussein
Oct 4, 2007·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Daniel D Billadeau
Aug 29, 2007·Neuroscience Letters·Toshihiro InoueHidenobu Tanihara
Jun 3, 2006·Journal of Cellular Biochemistry·Stéphane TerryRalph Buttyan
Apr 28, 2012·International Journal of Cancer. Journal International Du Cancer·R Siobhan DarringtonRobert M Kypta
Jan 14, 2010·Journal of Neurochemistry·Zafira CastañoRobert M Kypta
Aug 26, 2006·Biochemical and Biophysical Research Communications·Shoshana TellAbigail S Hackam
Jul 19, 2005·Cancer Letters·Meletios Verras, Zijie Sun
Jul 27, 2005·Biochemical and Biophysical Research Communications·Abbas ShakooriToshinari Minamoto
Aug 25, 2015·Interdisciplinary Sciences, Computational Life Sciences·Namachivayam BalakrishnanNaresh Kandakatla
Sep 1, 2006·Biochimica Et Biophysica Acta·Pierre D McCrea, Jae-Il Park
Mar 26, 2011·The American Journal of Pathology·Paola de CandiaLilia Alberghina
Jul 18, 2016·Cancer Letters·Andrey UgolkovAndrew P Mazar
Oct 29, 2014·Experimental Biology and Medicine·Nuray VarolCenk Y Bilen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.